Top Glove - CGS-CIMB Research 2020-05-13: Big Is Beautiful


Top Glove - Big Is Beautiful

  • We reiterate our positive view on Top Glove (SGX:BVA), post hosting a conference call with its management for 60 buy-side analysts and fund managers.
  • Top Glove is confident of posting margin expansion in coming quarters from:
    • higher glove sales,
    • better pricing, and
    • lower raw material prices.
  • Maintain ADD with an unchanged Target Price of RM10.40 (32x CY21 P/E).

Secured orders up to Apr 2021

  • The Covid-19 pandemic has resulted in Top Glove securing glove orders up until Mar-Apr 2021. This indicates that its current order lead time has been extended to 10-11 months (from an average of 30-40 days pre-Covid-19), which is testament to the current strong global glove demand.
  • In order to prevent customers from forfeiting their orders nearer their delivery dates, Top Glove now requires a 20% deposit before locking-in capacity for its customers.

More ASP increases on the cards

  • We gather that ASPs that are quoted to its customers are revised on a monthly basis, depending on supply-demand dynamics in the sector.
  • Given the current robust global glove demand, Top Glove is planning to raise ASPs by 5% monthly from the period of Jun to Aug 2020, and by 10% monthly from Sep 2020 onwards. This is post raising its ASPs by 3-5% monthly for the period of Feb-May 2020.

Current strong global glove demand likely to continue

  • Top Glove also shared its view that the current global glove demand is likely to remain robust for at least the next 10-12 months. This is given that Top Glove has never before witnessed such strong glove demand, leading to its current 10-11 months order lead time.
  • During the last global disease outbreak (H1N1 in 2010-11), we gather that Top Glove’s order lead-time was only four months and it witnessed robust global glove demand that was sustained for up to five quarters.

Potential margin expansion from 3QFY8/20 onwards

  • Top Glove expects to record higher EBITDA margin of 25-26% from 3QFY8/20 onwards. (1HFY8/20: 16.3%). This is on the back of:
    1. surge in glove demand leading to higher sales and ASPs,
    2. higher economies of scale, and
    3. favourable operating environment (lower raw material prices and weaker RM/US$).
  • Note that, this is broadly in-line with our FY20F EBITDA margin estimates of 20.1%.

Maintain ADD with an unchanged Target Price of RM10.40

Walter AW CGS-CIMB Research | https://www.cgs-cimb.com 2020-05-13
SGX Stock Analyst Report ADD MAINTAIN ADD 10.40 SAME 10.40